Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
San Raffaele University
Fudan University
St. Jude Children's Research Hospital
Novartis
GlaxoSmithKline
UNICANCER
ImmunityBio, Inc.
Sun Yat-sen University
7 Hills Pharma, LLC
University of Pittsburgh
AIO-Studien-gGmbH
GERCOR - Multidisciplinary Oncology Cooperative Group
Sanford Health
M.D. Anderson Cancer Center
WellSpan Health
Sun Yat-sen University
Incyte Corporation
Ohio State University Comprehensive Cancer Center
San Raffaele University
Molecular Templates, Inc.
Massachusetts General Hospital
West China Hospital
Henan Cancer Hospital
Institut Bergonié
Third Affiliated Hospital, Sun Yat-Sen University
National Institutes of Health Clinical Center (CC)
University of Colorado, Denver
Incyte Corporation